Factors of early protective action of live influenza vaccine combined with recombinant bacterial polypeptides against homologous and heterologous influenza infection-Reference-Cited by-同舟云学术

Factors of early protective action of live influenza vaccine combined with recombinant bacterial polypeptides against homologous and heterologous influenza infection

Published:2019-02 Issue:2 Volume:5 Page:e01154
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Desheva Yulia A.^ORCID,Leontieva Galina F.^ORCID,Kramskaya Tatiana A.,Landgraf Galina O.,Sychev Ivan A.^ORCID,Rekstin Andrey R.^ORCID,Suvorov Alexander N.

Funder

Institute of Experimental Medicine

Grants of the St. Petersburg Government

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference35 articles.

1. Evaluation in mouse model of combined virus-bacterial vaccine based on attenuated influenza A(H7N3) virus and the group b streptococcus recombinant polypeptides;Desheva;Open Microbiol. J.,2016

2. Prevention of influenza A(H7N9) and bacterial infections in mice using intranasal immunization with live influenza vaccine and the group B streptococcus recombinant polypeptides;Desheva;Virol. Res. Treat.,2017

3. Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression;Julkunen;Cytokine Growth Factor Rev.,2001

4. Molecular Pathways in virus-induced cytokine production;Mogensen;Microbiol. Mol. Biol. Rev.,2001

5. Cytokines in the pathogenesis of influenza;Van Reeth;Vet. Microbiol.,2000

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Live Influenza Vaccine Provides Early Protection against Homologous and Heterologous Influenza and May Prevent Post-Influenza Pneumococcal Infections in Mice;Microorganisms;2022-06-02

2. Associated virus-bacterial vaccine based on seasonal LAIV and S. pneumoniae chimeric peptide provide protection against post-influenza pneumococcal infection in mouse model;Virulence;2022-03-10

3. Combined immunization with attenuated live influenza vaccine and chimeric pneumococcal recombinant protein improves the outcome of virus-bacterial infection in mice;PLOS ONE;2019-09-12